Literature DB >> 21445697

Techniques for phenotyping coronary artery disease in the cardiac catheterization laboratory for applications in translational research.

Michael Ragosta1.   

Abstract

The catheterization laboratory is an excellent resource for translational research projects requiring phenotypic analysis of coronary artery disease. Coronary angiography, a traditional method of quantifying coronary disease, remains useful for describing the extent and the severity of angiographic coronary disease but is limited by the fact that angiography only depicts the effect of atherosclerosis on the arterial lumen. For this reason, quantitative coronary angiography has been supplemented by intravascular ultrasound and other catheter-based techniques and non-invasive methods for studies involving atherosclerosis progression and regression. Other angiographic based techniques potentially useful in research include the semi-quantification of collateral circulation, thrombolysis in myocardial infarction (TIMI) frame count, and TIMI blush score. The invasive assessment of coronary flow reserve and fractional flow reserve is a valuable adjunctive technique and can be used to precisely quantify the extent of ischemia or the presence of microvascular disease. Intravascular ultrasound (IVUS) is currently considered the gold standard for early diagnosis of coronary atherosclerosis and for measuring plaque burden. The serial measurements of changes in plaque volume over time are a valuable method of discerning plaque progression and regression. Similarly, radiofrequency backscatter IVUS, a relatively new imaging modality, can be used to describe and track changes in plaque composition.

Entities:  

Mesh:

Year:  2011        PMID: 21445697     DOI: 10.1007/s12265-011-9274-2

Source DB:  PubMed          Journal:  J Cardiovasc Transl Res        ISSN: 1937-5387            Impact factor:   4.132


  28 in total

Review 1.  Quantitative coronary angiography in regression trials: a review of methodologic considerations, endpoint selection, and limitations.

Authors:  Alexandra J Lansky; Kartik Desai; Martin B Leon
Journal:  Am J Cardiol       Date:  2002-02-21       Impact factor: 2.778

2.  Multimodality imaging atlas of coronary atherosclerosis.

Authors:  Patrick Donnelly; Pál Maurovich-Horvat; Marc Vorpahl; Masataka Nakano; Ryan K Kaple; William Warger; Atsushi Tanaka; Guillermo Tearney; Renu Virmani; Udo Hoffmann
Journal:  JACC Cardiovasc Imaging       Date:  2010-08

3.  Physiological assessment of coronary artery disease in the cardiac catheterization laboratory: a scientific statement from the American Heart Association Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology.

Authors:  Morton J Kern; Amir Lerman; Jan-Willen Bech; Bernard De Bruyne; Eric Eeckhout; William F Fearon; Stuart T Higano; Michael J Lim; Martijn Meuwissen; Jan J Piek; Nico H J Pijls; Maria Siebes; Jos A E Spaan
Journal:  Circulation       Date:  2006-08-28       Impact factor: 29.690

Review 4.  Advances in intravascular imaging.

Authors:  Akiko Maehara; Gary S Mintz; Neil J Weissman
Journal:  Circ Cardiovasc Interv       Date:  2009-10       Impact factor: 6.546

Review 5.  Intravascular imaging tools in the cardiac catheterization laboratory: comprehensive assessment of anatomy and physiology.

Authors:  Parham Eshtehardi; Jennifer Luke; Michael C McDaniel; Habib Samady
Journal:  J Cardiovasc Transl Res       Date:  2011-04-01       Impact factor: 4.132

6.  Angiographic versus functional severity of coronary artery stenoses in the FAME study fractional flow reserve versus angiography in multivessel evaluation.

Authors:  Pim A L Tonino; William F Fearon; Bernard De Bruyne; Keith G Oldroyd; Massoud A Leesar; Peter N Ver Lee; Philip A Maccarthy; Marcel Van't Veer; Nico H J Pijls
Journal:  J Am Coll Cardiol       Date:  2010-06-22       Impact factor: 24.094

7.  Effect of torcetrapib on the progression of coronary atherosclerosis.

Authors:  Steven E Nissen; Jean-Claude Tardif; Stephen J Nicholls; James H Revkin; Charles L Shear; William T Duggan; Witold Ruzyllo; William B Bachinsky; Gabriel P Lasala; Gregory P Lasala; E Murat Tuzcu
Journal:  N Engl J Med       Date:  2007-03-26       Impact factor: 91.245

8.  Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial.

Authors:  Steven E Nissen; E Murat Tuzcu; Paul Schoenhagen; B Greg Brown; Peter Ganz; Robert A Vogel; Tim Crowe; Gail Howard; Christopher J Cooper; Bruce Brodie; Cindy L Grines; Anthony N DeMaria
Journal:  JAMA       Date:  2004-03-03       Impact factor: 56.272

9.  Prognostic value of a coronary artery jeopardy score.

Authors:  R M Califf; H R Phillips; M C Hindman; D B Mark; K L Lee; V S Behar; R A Johnson; D B Pryor; R A Rosati; G S Wagner
Journal:  J Am Coll Cardiol       Date:  1985-05       Impact factor: 24.094

10.  Plaque characterisation by Virtual Histology intravascular ultrasound analysis in patients with type 2 diabetes.

Authors:  K Nasu; E Tsuchikane; O Katoh; H Fujita; J-F Surmely; M Ehara; Y Kinoshita; N Tanaka; T Matsubara; Y Asakura; K Asakura; M Terashima; T Suzuki
Journal:  Heart       Date:  2007-07-23       Impact factor: 5.994

View more
  3 in total

1.  Association of biomarkers of lipid modification with functional and morphological indices of coronary stenosis severity in stable coronary artery disease.

Authors:  Olivier Muller; Argyrios Ntalianis; William Wijns; Leen Delrue; Karen Dierickx; Reto Auer; Nicolas Rodondi; Fabio Mangiacapra; Catalina Trana; Michalis Hamilos; Emmanuel Valentin; Bernard De Bruyne; Emanuele Barbato; Jozef Bartunek
Journal:  J Cardiovasc Transl Res       Date:  2013-05-14       Impact factor: 4.132

2.  A functionally significant polymorphism in ID3 is associated with human coronary pathology.

Authors:  Ani Manichaikul; Stephen S Rich; Heather Perry; Joseph Yeboah; Michelle Law; Molly Davis; Matthew Parker; Michael Ragosta; Jessica J Connelly; Coleen A McNamara; Angela M Taylor
Journal:  PLoS One       Date:  2014-03-06       Impact factor: 3.240

3.  Correlation between the serum procalcitonin level and the extension and severity of coronary artery disease in patients with non-ST-segment elevation myocardial infarction.

Authors:  Seyed-Vahid Hashemipour; Hamidreza Pourhosseini; Ali Hosseinsabet
Journal:  Cardiovasc Endocrinol Metab       Date:  2019-05-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.